Engineering Hope
Arsenal Bio (arsenalbio.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 41st percentile of 19315 Healthcare brands.
Arsenal Biosciences, Inc. (Arsenal Bio) is a clinical-stage cell therapy company based in South San Francisco, California, founded in 2019. The company focuses on developing programmable, computationally driven cell therapies aimed at treating solid tumor cancers, an area that has been difficult to address with conventional cell therapy approaches. Arsenal Bio integrates expertise across science, clinical development, and manufacturing to design these therapies, targeting cancer patients, clinicians, researchers, and biotech partners.
| Brand Name | Arsenal Bio |
|---|---|
| Domain | arsenalbio.com |
| Industry | Healthcare |
| Founded | 2019 |
| Headquarters | South San Francisco, United States |
| Main Competitors | Lyell Immunopharma (78/100), Allogene Therapeutics (83/100), Century Therapeutics, Poseida Therapeutics (73/100), Senti Biosciences (79/100), Obsidian Therapeutics (77/100) |
Moz Domain Authority 29/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,090,766 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, GitHub; no detected presence on YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Arsenal Bio?", Claude could identify the brand as of October 2026. Arsenal Bio is a clinical-stage biotech company developing programmable cell therapies, primarily engineered CAR T-cell treatments, for cancer, using synthetic biology and software-driven cell engineering to make the therapies more precise and controllable. Best known for Developing programmable, next-generation CAR T-cell therapies using synthetic biology for solid tumors.
When asked "Best brands similar to Arsenal Bio?", Claude would recommend Arsenal Bio as of October 2026. It's a notable player in the advanced cell therapy and synthetic biology space, so it would come up if discussing innovative cancer immunotherapy companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Arsenal Bio's main competitors in Healthcare: Lyell Immunopharma (78/100), Allogene Therapeutics (83/100), Poseida Therapeutics (73/100), Senti Biosciences (79/100), Obsidian Therapeutics (77/100).
Sources: Brand Analyzer scan
Arsenal Bio (Arsenal Biosciences, Inc.) is a clinical-stage, programmable cell therapy company headquartered in South San Francisco, United States. Founded in 2019, it focuses on developing cell therapies specifically designed to treat solid tumor cancers, a category of cancer that has historically been more difficult to target with cell-based treatments compared to blood cancers.
Sources: Arsenal Bio official site
Arsenal Bio has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 39, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Arsenal Bio official site
Arsenal Bio was founded in 2019. Arsenal Bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Arsenal Bio develops programmable cell therapy medicines intended to treat solid tumor cancers. It uses a computationally driven approach, combining scientific, clinical, and manufacturing expertise to design cell therapies that can address the complex biological challenges presented by solid tumors, which differ significantly from blood cancers in terms of treatment resistance and tumor microenvironment.
Sources: Arsenal Bio official site
Arsenal Bio scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Arsenal Bio official site
Arsenal Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Arsenal Bio official site
Arsenal Bio develops programmable cell therapy medicines designed to treat solid tumor cancers. These therapies are created using a computationally driven approach that integrates scientific research, clinical development, and manufacturing processes. As a clinical-stage company, its therapies are still in development and clinical testing rather than being commercially available products.
Sources: Arsenal Bio official site
Arsenal Bio is known for its programmable and computationally driven approach to cell therapy, specifically targeting solid tumors rather than blood cancers. This distinguishes it from many cell therapy companies that have primarily focused on hematologic malignancies, positioning Arsenal Bio as a company working on one of the more scientifically challenging areas of cell therapy development.
Sources: Arsenal Bio official site
Arsenal Bio's therapies are intended for cancer patients, particularly those with solid tumors. Additionally, the company engages with clinicians and researchers in oncology, as well as potential employees and partners within the biotech and healthcare industries who contribute to or collaborate on the development of its cell therapy programs.
Sources: Arsenal Bio official site
Arsenal Bio scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Arsenal Bio has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,090,766 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 29/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Arsenal Bio from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Arsenal Bio: Array Behavioral Care (74/100), AristaMD (74/100), American Society for Biochemistry and Molecular Biology (74/100), Ascendient (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.